Mucoadhesive drug delivery systems

Drug Development and Industrial Pharmacy

Volumn 23, Issue 5, 1997, Pages 489-515

  Ahuja, Alka ^a   Khar, Roop K ^a   Ali, Javed ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; BECLOMETASONE DIPROPIONATE; BUDESONIDE; BUPRENORPHINE; CARBOPOL 934; CARBOPOL 940; CARBOXYMETHYLCELLULOSE; CETYLPYRIDINIUM SALT; CHITOSAN; DILTIAZEM; FLUORIDE SODIUM; GELATIN; GLYCERYL TRINITRATE; GUAR GUM; HYDROXYETHYLCELLULOSE; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; INSULIN; ISOSORBIDE DINITRATE; KETOPROFEN; LIDOCAINE; METOCLOPRAMIDE; METRONIDAZOLE; NIFEDIPINE; PECTIN; POLYACRYLIC ACID; POLYCARBOPHIL; POLYMER; PROCHLORPERAZINE; PROPRANOLOL; REPLENS; RETINOIC ACID; STARCH; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; XANTHAN;

BIOAVAILABILITY; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG RELEASE; HUMAN; MEMBRANE BINDING; MUCOSA; REVIEW; THEORY;

EID: 0030902837     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709148498     Document Type: Review

References (144)

1. M. R. Jimenez-Castellanos, H. Zia, and C. T. Rhodes, Drug Dev. Ind. Pharm., 19(1&2), 143 (1993).
2. ASTM Designation D 907-77, American Society for Testing and Materials, Philadelphia, 1984.
3. R. J. Good, J. Adhesion, 8, 1 (1976).
4. N. A. Peppas and P. A. Buri, J. Contr. Rel., 2, 257 (1985).
5. M. A. Longer and J. R. Robinson, Pharm. Int., 7, 114 (1987).
6. A. Gayot, J. Pharm. Belg., 40, 332 (1985).
7. J. R. Robinson, M. A. Longer, and M. Veillard, Ann. NY Acad. Sci., 507, 307 (1987).
8. S. H. S. Leung and J. R. Robinson, J. Contr. Rel., 12, 187 (1990).
9. K. Park and H. Park, Test methods of bioadhesion, in Bioadhesive Drug Delivery Systems (V. Lenaerts and R. Gurny, eds.), CRC Press, Boca Raton, FL, 1990, p. 43.
10. J. G. Edwards, The biochemistry of cell adhesion, Progr. Surf. Sci., 13, 125 (1983).
11. F. Grinnell, Cellular adhesiveness and extra cellular substrata, Int. Rev. Cytol., 53, 65 (1978).
12. T. Nagai and Y. Machida, Pharm. Int., 6, 196 (1985).
13. K. R. Kamath and K. Park, Mucosal adhesive preparations, in Encyclopedia of Pharmaceutical Technology, Vol. 10 (J. Swarbrick and J. C. Boylan, eds.), Marcel Dekker, New York, 1994, p. 133.
14. R. B. Gandhi and J. R. Robinson, Indian J. Pharm. Sci., 50, 145 (1988).
15. M. J. Rathbone and J. Hadgraft, Int. J. Pharm., 74, 9 (1991).
16. D. Duchene, F. Touchard, and N. A. Peppas, Drug Dev. Ind. Pharm., 14, 283 (1988).
17. P. B. V. Wachem, T. Beugeling, J. Feijen, A. Bantjes, J. P. Detmers, and W. G. V. Akhen, Biomaterials, 6, 403 (1985).
18. A. G. Mikos and N. A. Peppas, Scaling concepts and molecular theories of adhesion of synthetic polymers to glycoproteinic networks, in Bioadhesive Drug Delivery Systems (V. Lenaerts and R. Gurny, eds.), CRC Press, Boca Raton, FL, 1990, p. 25.
19. H. S. Ch'ng, H. Park, P. Kelly, and J. R. Robinson, J. Pharm. Sci., 74, 399 (1985).
20. C. M. Lehr, F. G. J. Poelma, H. E. Junginger, and J. J. Tukker, Int. J. Pharm., 70, 235 (1991).
21. N. Konietzko, Eur. J. Respir. Dis., 69, 72 (1986).
22. H. Park and J. R. Robinson, J. Contr. Rel., 2, 47 (1985).
23. M. Ishida, Y. Machida, N. Nambu, and T. Nagai, Chem. Pharm. Bull., 29, 810 (1981).
24. M. Marvola, K. Vahervou, and M. Rajaneimi, J. Pharm. Sci., 71, 975 (1982).
25. M. Marvola, M. Rajaneimi, E. Marttila, K. Vahervuo, and A. Sothmann, J. Pharm. Sci., 72, 1034 (1983).
26. H. Park and J. R. Robinson, Pharm. Res., 4, 457 (1987).
27. G. Ponchel, F. Touchard, D. Wouessidjewe, D. Duchene, and N. A. Peppas, Int. J. Pharm., 38, 65 (1987).
28. F. Lejoyeux, G. Ponchel, D. Wousessidjewe, N. A. Peppas, and D. Duchene, Drug Dev. Ind. Pharm., 15, 2037 (1989).
29. J. D. Smart, Int. J. Pharm., 73, 69 (1991).
30. K. Satoh, K. Takayama, Y. Machida, Y. Suzuki, M. Nakagaki, and T. Nagai, Chem. Pharm. Bull., 37, 1366 (1989).
31. P. Bottenberg, R. Cleymaet, C. D. Mynck, J. P. Remen, D. Coomans, Y. Michotte, and D. Slop, J. Pharm. Pharmacol., 43, 457 (1991).
32. P. Bottenberg, J. Herman, D. Coomans, C. De Muynck, J. P. Remon, D. Slop, and Y. Michotte, STP Pharma, 5, 863 (1989).
33. C. M. Lehr, J. A. Bouwstra, J. J. Tukker, and H. E. Junginger, J. Contr. Rel., 13, 51 (1990).
34. M. F. Saettone, P. Chetoni, M. T. Torracca, and S. Burgalassi, Int. J. Pharm., 51, 203 (1989).
35. W. G. Chen and G. C-C. Hwang, Int. J. Pharm., 82, 61 (1992).
36. C. M. Lehr, J. A. Bouwstra, E.H. Schacht, and H. E. Junginger, Int. J. Pharm., 78, 43 (1992).
37. D. Chickering, J. Jacob, G. Panol, and E. Mathiowitz, Proc. Int. Symp. Control. Rel. Bioact. Mater., 19, 88 (1992).
38. A. Gupta, S. Garg, and R. K. Khar, Indian Drugs, 30, 152 (1992).
39. F. Thermes, J. Grove, A. Rozier, B. Plazonnet, A. Constancis, C. Bunel, and J. P. Vairon, Pharm. Res., 9, 1563 (1992).
40. S. Bouckaert and J. P. Remon, J. Pharm. Pharmacol., 45, 504 (1993).
41. M. R. Jimenez-Castellanos, H. Zia, and C. T. Rhodes, Int. J. Pharm., 89, 223 (1993).
42. J. H. Guo, J. Pharm. Pharmacol., 46, 647 (1994).
43. J. H. Guo, Drug Dev., Ind. Pharm., 20, 2809 (1994).
44. T. Save, U. M. Shah, A. R. Ghamande, and P. Venkitachalam, J. Pharm. Pharmacol., 46, 192 (1994).
45. S. Miyazaki, A. Nakayama, M. Oda, M. Takada, and D. Attwood, Biol. Pharm. Bull., 17, 745 (1994).
46. A. Ahuja, M. Dogra, and S. P. Agarwal, Indian J. Pharm. Sci., 57, 26 (1995).
47. L. Martini, D. Attwood, J. H. Collect, and A. D'Emanucle, Int. J. Pharm., 113, 223 (1995).
48. M. Rillosi and G. Buckton, Int. J. Pharm., 117, 75 (1995).
49. J. D. Smart, I. W. Kellaway, and H. E. C. Worthington, J. Pharm. Pharmacol., 36, 295 (1984).
50. J. D. Smart and I. W. Kellaway, J. Pharm. Pharmacol., 34 (Suppl.), 70P (1982).
51. M. Ishida, M. Nambu, and T. Nagai, Chem. Pharm. Bull., 31, 1010 (1983).
52. R. Gurney, J. M. Meyer, and N. A. Peppas, Biomaterials, 5, 336 (1984).
53. A. P. Sam, J. T. M. Vanden Heuji, and J. J. Tukker, Int. J. Pharm., 79, 97 (1992).
54. K. Park and R. Robinson, Int. J. Pharm., 19, 107 (1984).
55. L. J. Kerr, I. W. Kellaway, C. Rowlands, and G. D. Parr, Proc. Int. Symp. Control. Rel. Bioact. Mater., 17, 122 (1990).
56. S. A. Mortazavi, B. G. Carpenter, and J. D. Smart, Int. J. Pharm., 83, 221 (1992).
57. S. A. Mortazavi, B. G. Carpenter, and J. D. Smart, Int. J. Pharm., 94, 195 (1993).
58. S. A. Mortazavi and J. D. Smart, J. Pharm. Pharmacol., 46, 86 (1994).
59. C. Caramella, S. Rossi, M. C. Bonferoni, and A. L. Manna, Proc. Int. Symp. Control. Rel. Bioact. Mater., 19, (1992).
60. J. D. Smart, Drug Dev. Ind. Pharm., 18, 223 (1992).
61. C. L. C. Teng and N. F. L. Ho, J. Contr. Rel., 6, 133 (1987).
62. K. V. R. Rao and P. Buri, Int. J. Pharm., 52, 265 (1989).
63. K. Park, Int. J. Pharm., 53, 209 (1989).
64. E. E. Hassan and J. M. Gallo, Pharm. Res., 7, 491 (1990).
65. R. Khosla and S. S. Davis, J. Pharm. Pharmacol., 39, 47 (1987).
66. R. S. Longer and N. A. Peppas, Biomaterials, 2, 201 (1981).
67. Handbook of Pharmaceutical Excipients, American Pharmaceutical Association publication, Washington, DC, 1986.
68. Carbopol Product Information, B. F. Goodrich and Co., Ohio, USA, 1994.
69. J. W. Wallace, Cellulose derivatives and natural products utilized, in Encyclopedia of Pharmaceutical technology, Vol. 2 (J. Swarbrick and J. C. Boylan, eds.), Marcel Dekker, New York, 1990, p. 319.
70. V. Kumar and G. S. Banker, Drug Dev. Ind. Pharm., 19, 1 (1993).
71. Methocel Product Information, Colorcon Ltd., U.K., 1993.
72. Y. Machida and T. Nagai, Chem. Pharm. Bull., 26, 6, 1652 (1978).
73. Y. Machida, H. Masuda, N. Fujiyama, S. Ito, M. Iwata, and T. Nagai, Chem. Pharm. Bull., 27, 1, 93 (1979).
74. M. Ishida, N. Nambu, and T. Nagai, Chem. Pharm. Bull., 30, 980 (1982).
75. A. E. Collins and P. B. Deasy, J. Pharm. Sci., 79, 2, 116 (1990).
76. A. Gupta, S. Garg, and R. K. Khar, Indian Drugs, 29(13), 586 (1992).
77. K. D. Bremecker, H. Strempel, and G. Klein, J. Pharm. Sci., 73, 548 (1984).
78. O. Kislal and N. Celebi, Proc. Int. Symp. Control. Rel. Bioact. Mater., 19, 397 (1992).
79. A. Gupta, S. Garg, and R. K. Khar, Drug Dev. Ind. Pharm., 20, 315 (1994).
80. M. J. Rathbone, Int. J. Pharm., 69, 103 (1991).
81. S. J. Sveinsson and W. P. Holbrook, Int. J. Pharm., 95, 105 (1993).
82. N. G. Gonzalez, Int. J. Pharm., 100, 65 (1993).
83. T. Save and P. Venkitachalam, Drug Dev. Ind. Pharm., 20, 3005 (1994).
84. K. Danjo, Y. Kitamura, Y. Miyagawa, and A. Otsuka, Chem. Pharm. Bull., 42, 2126 (1994).
85. M. M. Veillard, M. A. Longer, and J. R. Robinson, J. Contr. Release., 6, 123 (1987).
86. W. Schurmann and P. Turner, J. Pharm. Pharmacol., 30, 137 (1978).
87. M. Tanaka, N. Yanagibashi, H. Fukuda, and T. Nagai, Chem. Pharm. Bull., 28(4), 1056 (1980).
88. T. Nagai, J. Contr. Release, 2, 121 (1985).
89. H. Yamahara, T. Suzuki, M. Mizobe, K. Noda, and M. Samejima, J. Pharm. Sci., 79(11), 963 (1990).
90. Y. Nozaki, M. Kakumato, M. Ohta, and K. Yukimatsu, Drug Dev. Ind. Pharm., 19(14), 1755 (1993).
91. E. A. Hosny and M. A. Al-Meshal, Drug Dev. Ind. Pharm., 20(17), 2715 (1994).
92. M. A. Longer, H. S. Ch'ng, and J. R. Robinson, J. Pharm. Sci., 74, 406 (1985).
93. J. Russell and P. Bass, Gastroenterology, 89, 307 (1985).
94. R. Ito, Y. Machida, T. Sannan, and T. Nagai, Int. J. Pharm., 61, 109 (1990).
95. J. M. Aiache, International Patent Publication WO 92/ 02209, 1992.
96. M. T. Decrosta, N. B. Jain, and E. M. Rudnic, U.S. Patent 4666705, 1987.
97. R. S. Matharu and N. M. Sanghavi, Drug Dev. Ind. Pharm., 18, 1567 (1992).
98. J. L. Richardson and L. Illum, Adv. Drug. Delivery Rev., 8, 341 (1992).
99. A. E. Rakoff, L. G. Feo, and L. Goldstein, Am. J. Obstet. Gynecol., 47, 467 (1994).
100. T. P. Foster and E. L. Parrot, J. Pharm. Sci., 799, 806 (1990).
101. Y. Machida, H. Masuda, N. Fujiyama, S. Ito, M. Iwata, and T. Nagai, Chem. Pharm. Bull., 28(4), 1125 (1980).
102. D. M. Maurice and S. Mishima, Ocular pharmacokinetics, in Handbook of Experimental Pharmacology, Vol. 69, (M. L. Sears, ed.), Springer-Verlag, Basel, 1984, p. 19.
103. H. W. Hui and J. R. Robinson, Int. J. Pharm., 26, 203 (1987).
104. T. Nagai, Y. Nishimoto, N. Namba, Y. Suzuki, and K. Sekine, J. Contr. Rel., 1, 15 (1989).
105. K. Morimoto, H. Tabata, and K. Morisaka, Chem. Pharm. Bull., 35, 3041 (1987).
106. L. Illum, STP Pharma, 3, 594 (1987).
107. L. Ilium, H. Jorgensen, H. Bisgaard, O. Krogsgaard, and N. Rossing, Int. J. Pharm., 39, 189 (1987).
108. L. G. J. Leede, A. G. Boer, E. Portzgen, J. Feijen, and D. D. Breimer, J. Contr. Rel., 4, 17 (1986).
109. M. C. Alfano, J. F. Drummund, and S. A. Miller, J. Dent. Res., 54, 1143 (1974).
110. I. A. Siegel, S. H. Hall, and R. Stambaugh, in Current Concepts of Histology of Oral Mucosa (C. A. Squier and J. Meyer, eds.), Springfield, IL, 1971, p. 274.
111. L. S. Shanker, Adv. Drugs Res., 1, 71 (1964).
112. J. M. Schor, S. S. Davis, A. Nigalaye, and S. Bolton, Drug Dev. Ind. Pharm., 9, 1359 (1983).
113. M. Ishida, Y. Machida, N. Nambu, and T. Nagai, Chem. Pharm. Bull., 29, 810 (1981).
114. J. L. Chen and G. N. Cyr, in Adhesion in Biological Systems (R. S. Manly, ed.), Academic Press, New York, 1970, p. 163.
115. T. Nagai and R. J. Konishi, Contr. Release, 6, 353 (1987).
116. A. Gupta, Development of mucoadhesive buccal drug delivery systems, M. Pharm. dissertation, Jamia Hamdard (1992).
117. T. Yotsuyanage, K. Yamamura, and Y. Akao, Lancet, 2, 613 (1985).
118. R. Anders and H. P. Merkle, Int. J. Pharm., 49, 231 (1981).
119. B. Young and K. Knutson, Proc. Int. Symp. Control. Rel. Bioact. Mater., 19, 397 (1992).
120. T. Save, U. M. Shah, A. R. Ghamande, and P. Venkitachalam, J. Pharm. Pharmacol., 46, 86 (1994).
121. Dinsheet, Development and evaluation of buccal dosage forms of Hydralazine HCl using bioadhesive polymers, M. Pharm. dissertation, Jamia Hamdard (1994).
122. S. Bouckaert, H. Schautteet, R. A. Lefebvre, J. P. Remon, and R. V. Clooster, Eur. J. Clin. Pharmacol., 43, 137 (1992).
123. D. Harris and J. R. Robinson, J. Pharm. Sci., 81(1), (1992).
124. T. Nagai, Med. Res. Rev., 6, 227 (1986).
125. D. Duchene and G. Ponchel, STP Pharma, 5, 830 (1989).
126. T. Nagai, Y. Machida, and R. Konishi, Bioadhesive dosage forms for buccal/gingival administration, in Bioadhesive Drug Delivery Systems (V. Lenaerts and R. Gurny, eds.), CRC Press, Boca Raton, FL, 1990, p. 137.
127. G. Hunt, P. Kearney, and I. W. Kellaway, Muco-adhesive polymers in drug delivery systems, in Drug Delivery Systems: Fundamentals and Techniques (P. Johnson and J. G. Lloyd-Jones, eds.), Ellis Horwood Series, Chichester, U.K., 1987, p. 180.
128. D. A. Hollingsbee and P. Timminis, Topical adhesive systems, in Bioadhesion - Possibilities and Future Trends (R. Gurny and H. E. Junginger, eds.), Wissenschaftliche Verlags gesellschaft GmbH, Stuttgart, 1989, p. 140.
129. T. Nagai and Y. Machida, Bioadhesive dosage forms for nasal administration, in Bioadhesive Drug Delivery Systems (V. Lenaerts and R. Gurny, eds.), CRC Press, Boca Raton, FL, 1990, p. 169.
130. S. H. S. Leung and J. R. Robinson, Polymer News, 15, 333 (1990).
131. R. N. Brogden, R. C. Heel, T. M. Speight, and G. S. Avery, Drugs, 27, 194 (1984).
132. S. Okabe, K. Takeuchi, H. Kumini, M. Kanno, and M. Kawashima, Dig. Dis. Sci., 28, 1034 (1983).
133. R. Nagashima, J. Clin. Gastroenterol., 3(Suppl. 2), 117 (1981).
134. O. H. Griesing, L. D. Bighley, and R. L. Iles, J. Clin. Gastroenterol., 3(Suppl. 2), 111 (1981).
135. W. S. Brooke, Am. J. Gastroenterol., 80, 206 (1985).
136. S. Nakazawa, R. Nagashima, and I. M. Samloff, Dig. Dis. Sci., 26, 297 (1981).
137. E. Beyssac, J. M. Aiache, C. Chezaubernarel, H. Caplain, M. J. Douin, and A. Renoux, Proc. Int. Symp. Control. Rel. Biact. Mater., Contr. Rel. Soc., 21, 891 (1994).
138. C. S. Rani, J. K. Pandit, D. Sampath Kumar, and R. Singh, Scientific Abstracts, 47th IPC, 1995.
139. K. Rajesh, Development and evaluation of muco-adhesive buccal tablets and films of clotrimazole for oral candidiasis, M.Pharm. dissertation, Jamia Hamdard (1995).
140. K. Rajesh, S. P. Agarwal, and A. Ahuja, Bucco-adhesive erodible carriers for local drug delivery: Design and standardization, Int. J. Pharm., in press, (1996).
141. K. D. Bremecker, Pharm. Ind., 45, 417 (1983).
142. Y. W. Chien, K. S. E. Su, and S. P. Chang, (eds.), Nasal Systemic Drug Delivery, Marcel Dekker, New York, 1994, pp. 1-25.
143. M. Taylor, Laryngoscope, 84, 612 (1974).
144. J. Voorspoel and J. P. Remon, Proc. Int. Symp. Control. Ref. Bioact. Mater., 21, 539 (1994).